About US
Contact us
-
UK reserves ready for Sierra Leone deployment to fight against EbolaThe UK reserves and approximately 100 regulars are set to be deployed to Sierra Leone to help fight the Ebola outbreak. Regular and reserve personnel from across three services are currently undergoi2014/12/15
-
Germany bans 80 generic drugs trialled at GVK Biosciences facility in IndiaGermany has banned 80 generic drugs that had clinical trials performed by GVK Biosciences in India and found to be substandard. The ban by Germany's Federal Institute for Drugs and Medical Devices (B2014/12/15
-
MD Anderson president applauds FDA's approval of new vaccine for HPV-related cancersThe Food and Drug Administration's (FDA) approval of a new vaccine that targets five additional strains of human papilloma virus (HPV) fortifies a proven cancer-prevention weapon, according to Ronald2014/12/15
-
Lupin Pharmaceuticals introduces authorized generic of Celebrex CapsulesPharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc. (collectively Lupin) has launched the authorized generic for G.D. Searle LLC's (a subsidiary of Pfizer Inc2014/12/12
-
GlaxoSmithKline Manufacturing and Packaging, United States of AmericaGlaxo Wellcome, (now known as GlaxoSmithKline), a UK-based pharmaceuticals company, instigated a project in 1999 to expand the 652,000ft² manufacturing and packaging plant in Zebulon, NC. The new2014/12/12
-
Germany bans 80 generic drugs trialled at GVK Biosciences facility in IndiaGermany has banned 80 generic drugs that had clinical trials performed by GVK Biosciences in India and found to be substandard. The ban by Germany's Federal Institute for Drugs and Medical Devices (B2014/12/12
-
Outcomes Based Healthcare secures £1m grant to transform diabetes careUK-based Outcomes Based Healthcare has secured a £1m match-funded grant from Innovate UK, to lead the drive towards a more personalised, data-driven approach to improving health outcomes in diab2014/12/11
-
SMC recommends GSK’s Incruse Ellipta to treat COPD within NHS ScotlandThe Scottish Medicines Consortium (SMC) has recommended GlaxoSmithKline's (GSK) Incruse Ellipta 55mcg (umeclidinium) to treat patients with chronic obstructive pulmonary (COPD) within NHS Scotland. T2014/12/11
-
Mylan announces U.S. launch of Celecoxib CapsulesMylan Inc. (Nasdaq: MYL) today announced the U.S. launch of its Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg, one of the first available generic versions of Pfizer's Celebrex®Capsules, wh2014/12/11
-
Catalent Biomanufacturing Center of Excellence, Madison, Wisconsin, United States of AmericaCatalent Pharma Solutions opened a state-of-the-art bio-manufacturing centre of excellence in Madison, Wisconsin, US, in April 2013. Following the inauguration, Catalent relocated its operations and 82014/12/10